Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Operating Cash Flow | -28.93 Million | -30.81 Million | -5.77 Million | -6.21 Million |
| Net Income | -39.76 Million | -40.33 Million | -6.38 Million | -5.78 Million |
| Depreciation & Amortization | 2.72 Million | 1.61 Million | 75 Thousand | 72 Thousand |
| Deferred income taxes | - | -152 Thousand | 152 Thousand | 505.00 |
| Stock-based compensation | 1.82 Million | 646 Thousand | 233 Thousand | 84 Thousand |
| Change in working capital | 6.26 Million | -2.33 Million | 306 Thousand | -589 Thousand |
| Other non-cash items | 9000.00 | 9.74 Million | -153 Thousand | -505.00 |
| Investing Cash Flow | -1.18 Million | -1.07 Million | -2.3 Million | -2.73 Million |
| Investments in PPE | -1.18 Million | -1.07 Million | -2.3 Million | -2.73 Million |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -1074.00 | -1016.00 | -2288.00 | -2686.00 |
| Financing Cash Flow | 5.28 Million | 72.33 Thousand | 7.44 Million | 8.7 Million |
| Debt repayment | -5 Million | -9.48 Million | -3.65 Million | -5 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 257 Thousand | -14.87 Million | - | - |
| Other Financing Activities | 10.02 Million | 72.33 Thousand | 11.09 Million | 8.7 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | 1.51 Million | 1 Million | 181 Thousand | -68 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 4.75 Million | -3.34 Million | 125 Thousand | -521 Thousand |
| Cash at beginning of period | 40.56 Million | 123 Thousand | 757 Thousand | 1.01 Million |
| Cash at end of period | 15.74 Million | 40.56 Million | 123 Thousand | 757 Thousand |
| Capital Expenditure | -1.18 Million | -1.07 Million | -2.3 Million | -2.73 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -24.82 Million | 40.44 Million | -634 Thousand | -253 Thousand |
| Free Cash Flow | -30.11 Million | -31.88 Million | -8.07 Million | -8.95 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.86 Million | -7.58 Million | -9.35 Million | -8.76 Million | -39.76 Million | -11.4 Million |
| Depreciation & Amortization | 841 Thousand | 797 Thousand | 755 Thousand | 721 Thousand | 2.72 Million | 694 Thousand |
| Deferred income taxes | -5.86 Million | -7.58 Million | -2.44 Million | -6.26 Million | - | - |
| Stock-based compensation | 427 Thousand | 478 Thousand | 410 Thousand | 449 Thousand | 1.82 Million | 608 Thousand |
| Change in working capital | -1.34 Million | 1.22 Million | -524 Thousand | 1.25 Million | 6.26 Million | 3.09 Million |
| Other non-cash items | 5.86 Million | 7.58 Million | 2.44 Million | 6.26 Million | 9000.00 | 3688.00 |
| Investing Cash Flow | 66 Thousand | -503 Thousand | -521 Thousand | -360 Thousand | -1.18 Million | -374 Thousand |
| Investments in PPE | -5000.00 | -503 Thousand | -521 Thousand | -360 Thousand | -1.18 Million | -374 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 71 Thousand | -503.00 | -495.00 | -346.00 | -1074.00 | -340.00 |
| Financing Cash Flow | 6.27 Million | 5.71 Million | -435 Thousand | 132 Thousand | 5.28 Million | 6000.00 |
| Debt repayment | - | -423 Thousand | -435 Thousand | - | -5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.27 Million | 6.14 Million | - | 257 Thousand | 257 Thousand | - |
| Other Financing Activities | -444 Thousand | 5718.00 | -435.00 | -125 Thousand | 10.02 Million | 6.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -677 Thousand | 472 Thousand | -522 Thousand | 1.78 Million | 1.51 Million | 167 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -672 Thousand | 755 Thousand | 522 Thousand | -522 Thousand | 4.75 Million | - |
| Cash at beginning of period | 6.19 Million | 6.06 Million | 15.74 Million | 22.3 Million | 40.56 Million | 29.68 Million |
| Cash at end of period | 6.59 Million | 6.19 Million | 6.06 Million | 15.74 Million | 15.74 Million | 22.3 Million |
| Capital Expenditure | -5000.00 | -503 Thousand | -521 Thousand | -360 Thousand | -1.18 Million | -374 Thousand |
| Effect of forex changes on cash | -6.26 Million | -7.71 Million | - | - | - | - |
| Net cash flow / Change in cash | 402 Thousand | 128 Thousand | -9.67 Million | -6.56 Million | -24.82 Million | -7.38 Million |
| Free Cash Flow | -5.94 Million | -5.59 Million | -9.23 Million | -6.69 Million | -30.11 Million | -7.38 Million |
9022
BLHEF
VGO
2388
AGHOL
4980